Market Overview

Revance Therapeutics (NASDAQ: RVNC)

0.00 0.00 (0.00%)

Analyst Ratings

DateResearch FirmActionCurrentPT
6/11/19BarclaysInitiates Coverage OnOverweight28.0
2/15/19Wells FargoInitiates Coverage OnMarket Perform
2/14/19H.C. WainwrightInitiates Coverage OnBuy25.0
1/29/19Stifel NicolausInitiates Coverage OnBuy50.0
11/16/18GuggenheimUpgradesBuy41.0
9/17/18JMP SecuritiesDowngradesMarket Perform
3/05/18Goldman SachsInitiates Coverage OnBuy60.0
1/09/18GuggenheimDowngradesNeutral
12/06/17GuggenheimInitiates Coverage OnBuy42.0
11/27/17BarclaysInitiates Coverage OnOverweight31.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter